연구 분야: Software Development
학회: Challenge on Head and Neck Tumor Segmentation for MRI-Guided Applications
Magnetic resonance (MR)-guided radiation therapy (RT) is enhancing head and neck cancer (HNC) treatment through superior soft tissue contrast and longitudinal imaging capabilities. However, manual tumor segmentation remains a significant challenge, spurring interest in artificial intelligence (AI)-driven automation. To accelerate innovation in this field, we present the Head and Neck Tumor Segmentation for MR-Guided Applications (HNTS-MRG) 2024 Challenge, a satellite event of the 27th International Conference on Medical Image Computing and Computer Assisted Intervention. This challenge addresses the scarcity of large, publicly available AI-ready adaptive RT datasets in HNC and explores the potential of incorporating multi-timepoint data to enhance RT auto-segmentation performance. Participants tackled two HNC segmentation tasks: automatic delineation of primary gross tumor volume (GTVp) and gross metastatic regional lymph nodes (GTVn) on pre-RT (Task 1) and mid-RT (Task 2) T2-weighted scans. The challenge provided 150 HNC cases for training and 50 for final testing hosted on grand-challenge.org using a Docker submission framework. In total, 19 independent teams from across the world qualified by submitting both their algorithms and corresponding papers, resulting in 18 submissions for Task 1 and 15 submissions for Task 2. Evaluation using the mean aggregated Dice Similarity Coefficient showed top-performing AI methods achieved scores of 0.825 in Task 1 and 0.733 in Task 2. These results surpassed clinician interobserver variability benchmarks, marking significant strides in automated tumor segmentation for MR-guided RT applications in HNC.
Department of Radiation Oncology The University of Texas MD Anderson Cancer Houston TX USA
MoldovaDepartment of Imaging Physics The University of Texas MD Anderson Cancer Houston TX USA
MoldovaDepartment of Radiation Oncology The University of Texas MD Anderson Cancer Houston TX USA
MoldovaDepartment of Radiation Oncology The University of Texas MD Anderson Cancer Houston TX USA
MoldovaTransitional Year Program Corewell Health Wiliam Beaumont Royal Oak MI USA
United StatesDepartment of Radiation Oncology The University of Texas MD Anderson Cancer Houston TX USA
MoldovaDepartment of Radiation Oncology The University of Texas MD Anderson Cancer Houston TX USA
MoldovaDepartment of Radiation Oncology The University of Texas MD Anderson Cancer Houston TX USA
MoldovaDepartment of Radiation Oncology University of Maryland School of Medicine Baltimore MD USA
MoldovaDepartment of Clinical Oncology and Nuclear Medicine Faculty of Medicine Alexandria University Alexandria Egypt
AndorraDepartment of Radiation Oncology The University of Texas MD Anderson Cancer Houston TX USA
MoldovaDepartment of Radiation Oncology The University of Texas MD Anderson Cancer Houston TX USA
MoldovaDepartment of Radiation Oncology The University of Texas MD Anderson Cancer Houston TX USA
MoldovaDepartment of Radiation Oncology The University of Texas MD Anderson Cancer Houston TX USA
MoldovaDepartment of Radiation Oncology The University of Texas MD Anderson Cancer Houston TX USA
MoldovaDepartment of Radiation Oncology The University of Texas MD Anderson Cancer Houston TX USA
MoldovaDepartment of Radiation Oncology The University of Texas MD Anderson Cancer Houston TX USA
MoldovaDepartment of Radiation Oncology The University of Texas MD Anderson Cancer Houston TX USA
MoldovaDepartment of Radiation Oncology The University of Texas MD Anderson Cancer Houston TX USA
MoldovaUT MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences Houston USA
MoldovaDepartment of Radiation Oncology The University of Texas MD Anderson Cancer Houston TX USA
MoldovaDepartment of Radiation Oncology The University of Texas MD Anderson Cancer Houston TX USA
MoldovaDepartment of Radiation Oncology The University of Texas MD Anderson Cancer Houston TX USA
MoldovaDepartment of Radiation Oncology The University of Texas MD Anderson Cancer Houston TX USA
Moldova| 발행 연도 | 2025년 |
|---|---|
| 인용수 | 0 |
| 출판 국가 | Moldova, Andorra, United States |
| 사이트 | Springer |
| 좋아요 수 | 0 |